Nicolas Floc'h

4PUBLICATIONS
79CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 29, 2026
AZ'4331 is a novel pan-TEAD auto-palmitoylation inhibitor for the treatment of Hippo pathway-altered cancers.

|May 28, 2026
A forward genetic screen identifies Sirtuin1 as a driver of neuroendocrine prostate cancer.

|Feb 02, 2026
Preclinical to Clinical Translation of Pharmacokinetic-Pharmacodynamic Relationship in EGFR Exon20Ins Mutations: A Modeling Framework for Irreversible Inhibitors.

Adriana Savoca, Diana Zindel, Radoslaw Polanski

|Apr 17, 2024
Overcoming Osimertinib Resistance with AKT Inhibition in EGFRm-Driven Non-Small Cell Lung Cancer with PIK3CA/PTEN Alterations.

Ursula Grazini, Aleksandra Markovets, Lucy Ireland

Pageof 1

Frequent Collaborators

2 joint publications

Man Xu

2 joint publications

Matthew J Martin

1 joint publications

Ursula Grazini

1 joint publications

Aleksandra Markovets